Literature DB >> 8717519

Antigen processing and presentation by the class I major histocompatibility complex.

I A York1, K L Rock.   

Abstract

Major histocompatibility complex (MHC) class I molecules bind peptides derived from cellular proteins and display them for surveillance by the immune system. These peptide-binding molecules are composed of a heavy chain, containing an antigen-binding groove, which is tightly associated with a light chain (beta 2-microglobulin). The majority of presented peptides are generated by degradation of proteins in the cytoplasm, in many cases by a large multicatalytic proteolytic particle, the proteasome. Two beta-subunits of the proteasome, LMP2 and LMP7, are inducible by interferon-gamma and alter the catalytic activities of this particle, enhancing the presentation of at least some antigens. After production of the peptide in the cytosol, it is transported across the endoplasmic reticulum (ER) membrane in an ATP-dependent manner by TAP (transporter associated with antigen presentation), a member of the ATP-binding cassette family of transport proteins. There are minor pathways for generating presented peptides directly in the ER, and some evidence suggests that peptides may be further trimmed in this location. The class I heavy chain and beta 2-microglobulin are cotranslationally translocated into the endoplasmic reticulum where their assembly may be facilitated by the sequential association of the heavy chain with chaperone proteins BiP and calnexin. The class I molecule then associates with the lumenal face of TAP where it is retained, presumably awaiting a peptide. After the class I molecule binds a peptide, it is released for exocytosis to the cell surface where cytotoxic T lymphocytes examine it for peptides derived from foreign proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8717519     DOI: 10.1146/annurev.immunol.14.1.369

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  128 in total

Review 1.  Specificity, restriction and effector mechanisms of immunoregulatory CD8 T cells.

Authors:  M Vukmanovic-Stejic; M J Thomas; A Noble; D M Kemeny
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

2.  The simian immunodeficiency virus envelope glycoprotein contains two epitopes presented by the Mamu-A*01 class I molecule.

Authors:  M Furchner; A L Erickson; T Allen; D I Watkins; A Sette; P R Johnson; C M Walker
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

3.  Ligand-independent assembly of recombinant human CD1 by using oxidative refolding chromatography.

Authors:  M M Altamirano; A Woolfson; A Donda; A Shamshiev; L Briseño-Roa; N W Foster; D B Veprintsev; G De Libero; A R Fersht; C Milstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

4.  The possible use of HLA-G1 and G3 in the inhibition of NK cell-mediated swine endothelial cell lysis.

Authors:  K Matsunami; S Miyagawa; R Nakai; A Murase; R Shirakura
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

5.  Antigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cells.

Authors:  J T Voeten; G F Rimmelzwaan; N J Nieuwkoop; R A Fouchier; A D Osterhaus
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

6.  Transfection of single-stranded hepatitis A virus RNA activates MHC class I pathway.

Authors:  K Suzuki; M Yanagi; A Mori-Aoki; E Moriyama; K J Ishii; L D Kohn
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

7.  Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein.

Authors:  J M Johnson; C Nicot; J Fullen; V Ciminale; L Casareto; J C Mulloy; S Jacobson; G Franchini
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

8.  Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulation.

Authors:  S Le Gall; F Buseyne; A Trocha; B D Walker; J M Heard; O Schwartz
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

9.  Physical and genetic mapping of the rainbow trout major histocompatibility regions: evidence for duplication of the class I region.

Authors:  Ruth B Phillips; Ana Zimmerman; Marc A Noakes; Yniv Palti; Matt R W Morasch; Lisa Eiben; Sandra S Ristow; Gary H Thorgaard; John D Hansen
Journal:  Immunogenetics       Date:  2003-10-18       Impact factor: 2.846

10.  Reduced expression of members of the mhc-i antigen processing machinery in ethnic Uighur women with cervical cancer in the Xinjiang region of China.

Authors:  A Haimiti; Y Hailiman; A Gulina; J Du; Z Hao; X L Rong; A Zainuer; W Qin; S Lalai
Journal:  Curr Oncol       Date:  2014-02       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.